Validation of HLAMatchmaker algorithm in identifying acceptable HLA mismatches for thrombocytopenic patients refractory to platelet transfusions

Transfusion

Volumn 48, Issue 10, 2008, Pages 2159-2166

  Brooks, Erin G ^b   MacPherson, Bruce R ^b   Fung, Mark K ^a,b  

^a FLETCHER ALLEN HEALTH CARE   (United States)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALGORITHM; ARTICLE; BLOOD DONOR; CLINICAL TRIAL; COMPUTER PROGRAM; CONTROLLED STUDY; CORRELATION ANALYSIS; DONOR SELECTION; FEMALE; HISTOCOMPATIBILITY COMPLEX; HLA MATCHING; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PREDICTION; PROSPECTIVE STUDY; REFRACTORY THROMBOCYTOPENIA; SEROLOGY; STATISTICAL ANALYSIS; THROMBOCYTE TRANSFUSION; THROMBOCYTOPHERESIS; VALIDATION STUDY;

ADULT; ALGORITHMS; BLOOD GROUP INCOMPATIBILITY; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TESTING; HUMANS; MIDDLE AGED; PLATELET TRANSFUSION; PROSPECTIVE STUDIES; THROMBOCYTOPENIA;

EID: 52949130556     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2008.01837.x     Document Type: Article

References (20)

1. Nance ST, Hsu S, Vassallo RR, Murphy S. Review: platelet matching for alloimmunized patients - room for improvement. Immunohematol 2004 20 : 80 8.
2. Yankee RA, Grumet FC, Rogentine GN. Platelet transfusion therapy. The selection of compatible platelet donors for refractory patients by lymphocyte HL-A typing. N Engl J Med 1969 281 : 1208 12.
3. Duquesnoy RJ, Filip DJ, Rodey GE, Rimm AA, Aster RH. Successful transfusion of platelets "mismatched" for HLA antigens to alloimmunized thrombocytopenic patients. Am J Hematol 1977 2 : 219 26.
4. Rachel JM, Summers TC, Sinor LT, Plapp FV. Use of a solid phase red blood cell adherence method for pretransfusion platelet compatibility testing. Am J Clin Pathol 1988 90 : 63 8.
5. Gelb AB, Leavitt AD. Crossmatch-compatible platelets improve corrected count increments in patients who are refractory to randomly selected platelets. Transfusion 1997 37 : 624 30.
6. Moroff G, Garratty G, Heal JM, MacPherson BR, Stroncek D, Huang ST, Ho W, Petz LD, Leach MF, Lennon SS. Selection of platelets for refractory patients by HLA matching and prospective crossmatching. Transfusion 1992 32 : 633 40.
7. Petz LD, Garratty G, Calhoun L, Clark BD, Terasaki PI, Gresens C, Gornbein JA, Landaw EM, Smith R, Cecka JM. Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity. Transfusion 2000 40 : 1446 56.
8. Schiffer CA. Management of patients refractory to platelet transfusion - an evaluation of methods of donor selection. In : Brown EB, editor. Progress in hematology. New York : Grune & Stratton 1987 91 114.
9. Duquesnoy RJ. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. I. Description of the algorithm. Hum Immunol 2002 63 : 339 52.
10. Duquesnoy RJ. A structurally based approach to determine HLA compatibility at the humoral immune level. Hum Immunol 2006 67 : 847 62.
11. Duquesnoy RJ. Structural epitope matching for HLA-alloimmunized thrombocytopenic patients: a new strategy to provide more effective platelet transfusion support? Transfusion 2008 48 : 221 7.
12. Nambiar A, Duquesnoy RJ, Adams S, Zhao Y, Oblitas J, Leitman S, Stroncek D, Marincola F. HLAMatchmaker-driven analysis of responses to HLA-typed platelet transfusions in alloimmunized thrombocytopenic patients. Blood 2006 107 : 1680 7.
13. Mori M, Beatty PG, Graves M, Boucher KM, Milford EL. HLA gene and haplotype frequencies in the North American population: the National Marrow Donor Program Donor Registry. Transplantation 1997 64 : 1017 27.
14. Sacher RA, Kickler TS, Schiffer CA, Sherman LA, Bracey AW, Shulman IA College of American Pathologists. Transfusion Medicine Resource Committee. Management of patients refractory to platelet transfusion. Arch Pathol Lab Med 2003 127 : 409 14.
15. Rodey GE. HLA beyond tears. Durango (CO) : De Novo, Inc 2000 : 180 8.
16. Duquesnoy RJ, Takemoto S, de Lange P, Doxiadis II, Schreuder GM, Persijn GG, Claas FH. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. III. Effect of matching at the HLA-A,B amino acid triplet level on kidney transplant survival. Transplantation 2003 75 : 884 9.
17. Goodman RS, Taylor CJ, O'Rourke CM, Lynch A, Bradley JA, Key T. Utility of HLAMatchmaker and single-antigen HLA-antibody detection beads for identification of acceptable mismatches in highly sensitized patients awaiting kidney transplantation. Transplantation 2006 81 : 1331 6.
18. Valentini RP, Nehlsen-Cannarella SL, Gruber SA, Mattoo TK, West MS, Lang C, Imam AA. Intravenous immunoglobulin, HLA allele typing and HLAMatchmaker facilitate successful transplantation in highly sensitized pediatric renal allograft recipients. Pediatr Transplant 2007 11 : 77 81.
19. Haririan A, Fagoaga O, Daneshvar H, Morawski K, Sillix DH, El-Amm JM, West MS, Garnick J, Migdal SD, Gruber SA, Nehlsen-Cannarella S. Predictive value of human leucocyte antigen epitope matching using HLAMatchmaker for graft outcomes in a predominantly African-American renal transplant cohort. Clin Transplant 2006 20 : 226 33.
20. Adeyi OA, Girnita AL, Howe J, Marrari M, Awadalla Y, Askar M, Martell J, Zeevi A, Shapiro R, Nalesnik M, Randhawa P, Demetris AJ, Duquesnoy RJ. Serum analysis after transplant nephrectomy reveals restricted antibody specificity patterns against structurally defined HLA class I mismatches. Transpl Immunol 2005 14 : 53 62.